Functional	O
assessment	O
of	O
human	S-SPECIES
enhancer	O
activities	O
using	O
whole	O
-	O
genome	O
STARR	O
-	O
sequencing	O
.	O


BACKGROUND	O
:	O
Genome	O
-	O
wide	O
quantification	O
of	O
enhancer	O
activity	O
in	O
the	O
human	S-SPECIES
genome	O
has	O
proven	O
to	O
be	O
a	O
challenging	O
problem	O
.	O


Recent	O
efforts	O
have	O
led	O
to	O
the	O
development	O
of	O
powerful	O
tools	O
for	O
enhancer	O
quantification	O
.	O


However	O
,	O
because	O
of	O
genome	O
size	O
and	O
complexity	O
,	O
these	O
tools	O
have	O
yet	O
to	O
be	O
applied	O
to	O
the	O
whole	O
human	S-SPECIES
genome	O
.	O


RESULTS	O
:	O
In	O
the	O
current	O
study	O
,	O
we	O
use	O
a	O
human	S-SPECIES
prostate	O
cancer	O
cell	O
line	O
,	O
LNCaP	O
as	O
a	O
model	O
to	O
perform	O
whole	O
human	S-SPECIES
genome	O
STARR	O
-	O
seq	O
(	O
WHG	O
-	O
STARR	O
-	O
seq	O
)	O
to	O
reliably	O
obtain	O
an	O
assessment	O
of	O
enhancer	O
activity	O
.	O


This	O
approach	O
builds	O
upon	O
previously	O
developed	O
STARR	O
-	O
seq	O
in	O
the	O
fly	O
genome	O
and	O
CapSTARR	O
-	O
seq	O
techniques	O
in	O
targeted	O
human	S-SPECIES
genomic	O
regions	O
.	O


With	O
an	O
improved	O
library	O
preparation	O
strategy	O
,	O
our	O
approach	O
greatly	O
increases	O
the	O
library	O
complexity	O
per	O
unit	O
of	O
starting	O
material	O
,	O
which	O
makes	O
it	O
feasible	O
and	O
cost	O
-	O
effective	O
to	O
explore	O
the	O
landscape	O
of	O
regulatory	O
activity	O
in	O
the	O
much	O
larger	O
human	S-SPECIES
genome	O
.	O


In	O
addition	O
to	O
our	O
ability	O
to	O
identify	O
active	O
,	O
accessible	O
enhancers	O
located	O
in	O
open	O
chromatin	O
regions	O
,	O
we	O
can	O
also	O
detect	O
sequences	O
with	O
the	O
potential	O
for	O
enhancer	O
activity	O
that	O
are	O
located	O
in	O
inaccessible	O
,	O
closed	O
chromatin	O
regions	O
.	O


When	O
treated	O
with	O
the	O
histone	O
deacetylase	O
inhibitor	O
,	O
Trichostatin	O
A	O
,	O
genes	O
nearby	O
this	O
latter	O
class	O
of	O
enhancers	O
are	O
up	O
-	O
regulated	O
,	O
demonstrating	O
the	O
potential	O
for	O
endogenous	O
functionality	O
of	O
these	O
regulatory	O
elements	O
.	O


CONCLUSION	O
:	O
WHG	O
-	O
STARR	O
-	O
seq	O
provides	O
an	O
improved	O
approach	O
to	O
current	O
pipelines	O
for	O
analysis	O
of	O
high	O
complexity	O
genomes	O
to	O
gain	O
a	O
better	O
understanding	O
of	O
the	O
intricacies	O
of	O
transcriptional	O
regulation	O
.	O
